Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?

Zacks Zacks
Open on Zacks
Will Archer Daniels' Strategic Moves & Cost Savings Aid Growth?

Archer Daniels Midland Company’s ADM strategic moves and cost-saving efforts are likely to support growth by improving efficiency, protecting margins and strengthening focus on higher-return businesses. The company is focused on optimizing the organizational and operational structure. ADM is strengthening its internal controls, enhancing execution, improving operational efficiency and reducing costs, while streamlining its portfolio to sharpen core competencies and unlock long-term value.

The company is actively managing productivity and innovation as well as aligning work to the interconnected trends in food security, health and wellbeing. Archer Daniels is smoothly progressing on its key strategic pillars, including optimize, drive and growth. ADM continues to adapt to consumers’ changing nutritional preferences and has expanded its alternative protein capabilities and starch production. ADM is focused on expanding its footprint in fast-growing alternative protein.

ADM has also been creating additional margin opportunities, opening up channels to customers, advancing digital technologies in areas like farmer needs, and growing its BioSolutions platform. It is broadening its growth opportunities by using its core processing assets in new ways. The company is expanding into biosolutions, precision fermentation and decarbonization, which can create additional revenue streams from existing operations.

In addition, Archer Daniels’ Nutrition segment is showing signs of recovery, led by improving performance in Human Nutrition. Management highlighted strength in the Flavors portfolio, supported by solid demand in North America and new international customer wins. Margin expansion in Flavors, driven by improved mix and pricing discipline, contributed meaningfully to profitability, while the Health & Wellness portfolio benefited from improving demand trends, including biotics.

The company is also advancing digital initiatives by pivoting toward regional, agile projects and accelerating its data and analytics capabilities, while maintaining investment in cybersecurity and network resilience. Hence, the company looks forward to making investments in its portfolio to bolster growth and differentiation, including plant digitization, operating leverage and higher marketing volumes in targeted markets.

ADM’s Price Performance, Valuation and Estimates

Archer Daniels shares have gained 33.7% in the past six months compared with the industry’s 13.5% growth.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, ADM trades at a forward price-to-earnings ratio of 17.14X compared with the industry’s average of 14.93X.

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for ADM’s 2026 and 2027 earnings per share (EPS) indicates year-over-year drop of 8% but that of 2027 reflects growth of 6.9%. The company’s EPS estimate for 2026 and 2027 has been stable in the past 30 days.

Zacks Investment Research
Image Source: Zacks Investment Research

Archer Daniels currently carries a Zacks Rank #2 (Buy).

Other Stocks to Consider in the Consumer Staples Space

The Chefs' Warehouse, Inc. CHEF, which is a distributor of specialty food products in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Chefs' Warehouse’s current financial-year sales indicates growth of 8.3% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 28.9%, on average.

Nomad Foods Limited NOMD, which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.

The Zacks Consensus Estimate for Nomad Foods’ current financial-year sales is expected to rise 0.5% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 8.6%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED beat the average earnings surprise of 65.5% in the last reported quarter. 

The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 26% from the year-ago number. 

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Archer Daniels Midland Company (ADM): Free Stock Analysis Report
 
The Chefs' Warehouse, Inc. (CHEF): Free Stock Analysis Report
 
MEDIFAST INC (MED): Free Stock Analysis Report
 
Nomad Foods Limited (NOMD): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research